Compare Nasdaq Inc (NDAQ) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq Inc vs GeneDx Holdings Corp — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Nasdaq Inc is far larger — about 28.9× GeneDx Holdings Corp's market cap, and Nasdaq Inc pays a 1.22% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| NDAQ | WGS | |
|---|---|---|
Market Cap | $51.96B | $1.80B |
Sector | Financials | Technology |
52-Week High | $100.98 | $167.51 |
52-Week Low | $76.85 | $34.51 |
Enterprise Value | $59.02B | $1.80B |
Dividend Yield | 1.22% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
